SDZ RAD inhibits cold ischemia-induced vascular remodeling

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1024-1025

  Schuurman, H J ^a   Pally, C ^a   Weckbecker, G ^a   Schuler, W ^a   Bruns, C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; GRAFT REJECTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT;

ADENOSINE; ALLOPURINOL; ANIMALS; AORTA, ABDOMINAL; COLD; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISCHEMIA; MALE; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SIROLIMUS; TRANSPLANTATION, ISOGENEIC;

EID: 0033057120     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01885-5     Document Type: Conference Paper

References (2)

1. Schuler W., Sedrani R., Cottens S., et al. Transplantation. 64:1997;36.
2. Schuurman H.-J., Cottens S., Fuchs S., et al. Transplantation. 64:1997;32.